Barcelona, Spain
Professor Paul Chatrath was an invited member on the International Advisory Board for Allergen, the company that manufactures the Earfold™ implant for prominent ear correction. Professor Chatrath was one of five experts invited to the conference in which the patient pathway from presentation right up to a decision to undergo prominent ear correction surgery was discussed in detail. This included analysis of complex cases and an in depth appraisal of the Earfold™ implant and its role in the management of prominent ears.